Article

Analyst Research

Report Title	Price
Thomson Reuters Stock Report - CIPLA LTD (CIPLA-IN) Provider: Thomson Reuters Stock Report	$25.00 Buy
Cipla falls 0.6% in weak trading with bearish open interest Provider: News Bites Pty Limited	$5.00 Buy
Cipla in its biggest trailing week gain for 3 months Provider: News Bites Pty Limited	$5.00 Buy
Cipla Ltd. (CIPLA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Cipla Ltd's Board Recommends Dividend

Thursday, 7 Jun 2012 07:17am EDT

Cipla Limited announced that the Board of Directors of the Company at its meeting held on June 07, 2012 has recommended payment of dividend of INR2 per equity share (face value INR2) for the year 2011-2012 amounting to INR160.58 crores (INR1.6058 billion)

Latest Developments for Cipla Ltd

Latest Key Developments in Pharmaceuticals

Share this
Link this
Digg this
Email

Share this
Digg this
Email
Print

Related Company News

Cipla Medpro shareholders back buyout by India's Cipla

Wed, May 15 2013

Cipla Medpro shareholders approve buyout by India's Cipla

Wed, May 15 2013

India's Cipla launches etanercept biosimilar

Wed, Apr 17 2013

Company Quote

Cipla Ltd

(CIPL.BO)

415.0

-0.25 -0.06%

23 May 2013

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Follow Reuters